← Back

Rapport Therapeutics, Inc.

RAPP
$45.49-1.86%

SEC Filings

Recommended10-Q · Aug 5, 2026

Not sure where to start? This is Rapport Therapeutics, Inc.'s most recent filing. Start with its AI summary.

Summarize this filing